Atlas Trials

Studying Complement Inhibition in Patients With Moderate to Severe Hidradenitis Suppurativa

Clinical trial NCT03001622 · COMPLETED

Trial details

NCT number
NCT03001622
Sponsor
InflaRx GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hidradenitis Suppurativa
Start date
2016-12-01
Primary completion
2017-07-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.